Camilla Ruffilli

Affiliations
  • Safety Innovation and PROTAC Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge CB2 0SL, United Kingdom.
  • Department of Medical Biochemistry, Amsterdam UMC, University of Amsterdam, Amsterdam 1000 GG, The Netherlands.

Publications (2)

Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation.

ACS pharmacology & translational science
Avec: Camilla Ruffilli , Sascha Roth , Monica Rodrigo , Helen Boyd , Noam Zelcer , Kevin Moreau

Cell cycle-dependent binding between Cyclin B1 and Cdk1 revealed by time-resolved fluorescence correlation spectroscopy.

Open biology
Avec: Martina Barbiero , Luca Cirillo , Sapthaswaran Veerapathiran , Catherine Coates , Camilla Ruffilli , Jonathon Pines

Réseau de co-auteurs

Sascha Roth 1 collaboration
Monica Rodrigo 1 collaboration
Helen Boyd 1 collaboration
Noam Zelcer 1 collaboration
Kevin Moreau 1 collaboration
Martina Barbiero 1 collaboration
Luca Cirillo 1 collaboration
Sapthaswaran Veerapathiran 1 collaboration
Catherine Coates 1 collaboration
Jonathon Pines 1 collaboration